Patients with Genetic Heart Disease and COVID-19: A Cardiac Society of Australia and New Zealand (CSANZ) Consensus Statement

Gray, Belinda and Semsarian, Christopher and Fatkin, Diane and Ingles, Jodie and Atherton, John J. and Davis, Andrew M. and Sanders, Prashanthan and Pachter, Nicholas and Skinner, Jonathan R. and Stiles, Martin K. (2020) Patients with Genetic Heart Disease and COVID-19: A Cardiac Society of Australia and New Zealand (CSANZ) Consensus Statement. Heart, Lung and Circulation. ISSN 14439506

[thumbnail of Gray - Heart Lung Circulation, 2020.pdf]
Preview
Text
Gray - Heart Lung Circulation, 2020.pdf
Available under License Creative Commons Attribution No Derivatives.

Download (206kB) | Preview
Link to published document: http://doi.org/10.1016/j.hlc.2020.04.006

Abstract

In the context of the current global COVID-19 pandemic, this Consensus Statement provides current recommendations for patients with, or at risk of developing, genetic heart disease, and for their health care management and service provision in Australia and New Zealand. Apart from general recommendations, there are specific recommendations for the following conditions: cardiomyopathy, Brugada syndrome (including in children), long QT syndrome (LQTS) and catecholaminergic polymorphic ventricular tachycardia (CPVT). Other recommendations are relevant to patient self-care and primary health care.

Item Type: Article
Subjects: R Medicine > R Medicine (General)
Depositing User: Repository Administrator
Date Deposited: 02 Jun 2020 03:33
Last Modified: 14 Oct 2021 05:21
URI: https://eprints.victorchang.edu.au/id/eprint/975

Actions (login required)

View Item View Item